# Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer

> **NCT04793633** · — · ENROLLING_BY_INVITATION · sponsor: **Adenocyte, LLC** · enrollment: 500 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **COMBINATION_PRODUCT:** LINFU™ Technique

## Key facts

- **NCT ID:** NCT04793633
- **Lead sponsor:** Adenocyte, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-01-31
- **Primary completion:** 2030-12-30
- **Final completion:** 2030-12-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04793633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04793633, "Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04793633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*